COLL logo

Collegium Pharmaceutical (COLL) EBITDA

Annual EBITDA

$308.33 M
+$135.02 M+77.91%

December 31, 2023

Summary

Performance

1-Year Change

+77.91%

3-Year Change

+161.26%

5-Year Change

+235.47%

15-Year Change

+515.14%

COLL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.43%
COLL annual EBITDA is higher than 90.43% of companies in Healthcare sector

High & Low

All-time High

$308.33 M
COLL annual EBITDA is currently at an all-time high

3-Year Low

$86.56 M
COLL annual EBITDA is currently +256.21% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
COLL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 21, 2025
COLL next annual earnings announcement is scheduled for Feb 21, 2025

OtherCOLLprofitabilitymetrics:

Annual Revenue

$566.77 M
COLL annual revenue is $566.77 million

Annual Net Income

$48.16 M
COLL annual net profit is $48.16 million

Annual EBIT

$159.07 M
COLL annual earnings before interest & taxes is $159.07 million

Annual EPS

$1.29
COLL annual earnings per share is $1.29

Quarterly EBITDA

$75.72 M
-$4.43 M-5.53%

September 30, 2024

Summary

Performance

3-Month Change

-5.53%

1-Year Change

-12.67%

3-Year Change

-12.67%

5-Year Change

-12.67%

COLL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.15%
COLL quarterly EBITDA is higher than 89.15% of companies in Healthcare sector

High & Low

All-time High

$101.45 M
COLL quarterly EBITDA is currently -25.36% below its historical high of $101.45 million

3-Year Low

-$16.90 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
COLL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
COLL next earnings announcement is scheduled for Feb 21, 2025

OtherCOLLprofitabilitymetrics:

Quarterly Revenue

$159.30 M
COLL quarterly revenue is $159.30 million

Quarterly Net Income

$9.34 M
COLL quarterly net profit is $9.34 million

Quarterly EBIT

$33.97 M
COLL quarterly earnings before interest & taxes is $33.97 million

Quarterly EPS

$0.27
COLL quarterly earnings per share is $0.27

TTM EBITDA

$346.72 M
-$10.98 M-3.07%

September 30, 2024

Summary

Performance

3-Month Change

-3.07%

1-Year Change

+31.95%

3-Year Change

+31.95%

5-Year Change

+31.95%

COLL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.51%
COLL TTM EBITDA is higher than 90.51% of companies in Healthcare sector

High & Low

All-time High

$357.70 M
COLL TTM EBITDA is currently -3.07% below its historical high of $357.70 million

3-Year Low

$57.76 M
COLL TTM EBITDA is currently +500.33% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
COLL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
COLL next earnings announcement is scheduled for Feb 21, 2025

OtherCOLLprofitabilitymetrics:

TTM Revenue

$599.25 M
COLL TTM revenue is $599.25 million

TTM Net Income

$88.59 M
COLL TTM net profit is $88.59 million

TTM EBIT

$198.61 M
COLL TTM earnings before interest & taxes is $198.61 million

TTM EPS

$2.33
COLL TTM earnings per share is $2.33

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$308.33 M
COLL annual EBITDA is $308.33 million

Annual Net Income

$48.16 M
COLL annual net profit is $48.16 million

Annual Interest Expense

$83.34 M
COLL annual interest expense is $83.34 million

Annual Income Tax

$27.58 M
COLL annual income tax is $27.58 million

Annual D&A

$149.26 M
COLL annual depreciation & amortization is $149.26 million

COLL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+77.9%-12.7%+31.9%
3 y3 years+161.3%-12.7%+31.9%
5 y5 years+235.5%-12.7%+31.9%

COLL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+256.2%-25.4%+548.0%-3.1%+500.3%
5 y5-yearat high+4970.9%-25.4%+548.0%-3.1%+5577.4%
alltimeall timeat high+430.0%-25.4%+377.5%-3.1%+444.1%

Collegium Pharmaceutical EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$75.72 M(-5.5%)
$346.72 M(-3.1%)
Jun 2024
-
$80.15 M(-10.3%)
$357.70 M(+0.6%)
Mar 2024
-
$89.39 M(-11.9%)
$355.57 M(+15.3%)
Dec 2023
$308.33 M(+77.9%)
$101.45 M(+17.0%)
$308.33 M(+17.3%)
Sep 2023
-
$86.70 M(+11.1%)
$262.76 M(+12.0%)
Jun 2023
-
$78.02 M(+85.1%)
$234.58 M(+14.0%)
Mar 2023
-
$42.15 M(-24.6%)
$205.83 M(+18.8%)
Dec 2022
$173.31 M(+100.2%)
$55.89 M(-4.5%)
$173.31 M(+72.4%)
Sep 2022
-
$58.52 M(+18.8%)
$100.52 M(+37.0%)
Jun 2022
-
$49.27 M(+411.8%)
$73.39 M(+27.1%)
Mar 2022
-
$9.63 M(-157.0%)
$57.76 M(-33.3%)
Dec 2021
$86.56 M(-26.7%)
-$16.90 M(-153.8%)
$86.56 M(-36.1%)
Sep 2021
-
$31.40 M(-6.6%)
$135.53 M(-3.7%)
Jun 2021
-
$33.63 M(-12.5%)
$140.75 M(+0.1%)
Mar 2021
-
$38.43 M(+19.8%)
$140.68 M(+19.2%)
Dec 2020
$118.01 M(-1964.4%)
$32.08 M(-12.4%)
$118.01 M(+34.4%)
Sep 2020
-
$36.62 M(+9.1%)
$87.83 M(+78.5%)
Jun 2020
-
$33.55 M(+112.8%)
$49.20 M(+227.4%)
Mar 2020
-
$15.77 M(+732.4%)
$15.03 M(-337.4%)
Dec 2019
-$6.33 M
$1.89 M(-194.1%)
-$6.33 M(-133.1%)
Sep 2019
-
-$2.01 M(+226.3%)
$19.10 M(-55.6%)
Jun 2019
-
-$617.00 K(-89.0%)
$43.04 M(-37.9%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$5.59 M(-120.5%)
$69.26 M(-24.6%)
Dec 2018
$91.91 M(-223.7%)
$27.33 M(+24.6%)
$91.91 M(+94.3%)
Sep 2018
-
$21.93 M(-14.4%)
$47.31 M(+286.1%)
Jun 2018
-
$25.60 M(+50.1%)
$12.25 M(-135.7%)
Mar 2018
-
$17.06 M(-198.7%)
-$34.34 M(-53.8%)
Dec 2017
-$74.27 M(-20.5%)
-$17.27 M(+31.5%)
-$74.27 M(-11.9%)
Sep 2017
-
-$13.13 M(-37.5%)
-$84.28 M(-13.4%)
Jun 2017
-
-$21.00 M(-8.2%)
-$97.32 M(-3.4%)
Mar 2017
-
-$22.87 M(-16.2%)
-$100.75 M(+7.8%)
Dec 2016
-$93.43 M(+249.4%)
-$27.28 M(+4.3%)
-$93.43 M(+23.5%)
Sep 2016
-
-$26.17 M(+7.1%)
-$75.63 M(+28.9%)
Jun 2016
-
-$24.43 M(+57.2%)
-$58.69 M(+51.3%)
Mar 2016
-
-$15.54 M(+63.9%)
-$38.79 M(+45.1%)
Dec 2015
-$26.74 M(+53.0%)
-$9.49 M(+2.8%)
-$26.73 M(+30.2%)
Sep 2015
-
-$9.23 M(+103.7%)
-$20.53 M(+15.6%)
Jun 2015
-
-$4.53 M(+29.7%)
-$17.76 M(+2.8%)
Mar 2015
-
-$3.49 M(+6.5%)
-$17.27 M(-1.2%)
Dec 2014
-$17.48 M(+9.6%)
-$3.28 M(-49.2%)
-$17.48 M(+23.1%)
Sep 2014
-
-$6.46 M(+59.8%)
-$14.20 M(+83.5%)
Jun 2014
-
-$4.04 M(+9.3%)
-$7.74 M(+109.3%)
Mar 2014
-
-$3.70 M
-$3.70 M
Dec 2013
-$15.95 M
-
-

FAQ

  • What is Collegium Pharmaceutical annual EBITDA?
  • What is the all time high annual EBITDA for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical annual EBITDA year-on-year change?
  • What is Collegium Pharmaceutical quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical quarterly EBITDA year-on-year change?
  • What is Collegium Pharmaceutical TTM EBITDA?
  • What is the all time high TTM EBITDA for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical TTM EBITDA year-on-year change?

What is Collegium Pharmaceutical annual EBITDA?

The current annual EBITDA of COLL is $308.33 M

What is the all time high annual EBITDA for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high annual EBITDA is $308.33 M

What is Collegium Pharmaceutical annual EBITDA year-on-year change?

Over the past year, COLL annual EBITDA has changed by +$135.02 M (+77.91%)

What is Collegium Pharmaceutical quarterly EBITDA?

The current quarterly EBITDA of COLL is $75.72 M

What is the all time high quarterly EBITDA for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high quarterly EBITDA is $101.45 M

What is Collegium Pharmaceutical quarterly EBITDA year-on-year change?

Over the past year, COLL quarterly EBITDA has changed by -$10.98 M (-12.67%)

What is Collegium Pharmaceutical TTM EBITDA?

The current TTM EBITDA of COLL is $346.72 M

What is the all time high TTM EBITDA for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high TTM EBITDA is $357.70 M

What is Collegium Pharmaceutical TTM EBITDA year-on-year change?

Over the past year, COLL TTM EBITDA has changed by +$83.96 M (+31.95%)